A federal judge in Minnesota has rescinded an order that prevented the Department of Homeland Security from destroying evidence connected to the fatal shooting of U.S. citizen Alex Pretti by ICE agents, allowing the controversial disposal process to move forward.
Thai military officials have revealed a massive cache of evidence, including scam scripts and fake police setups, seized from a contested border compound in Cambodia, shedding light on the scale of transnational cyber fraud operations in the region.
Boston Scientific's latest earnings beat and raised guidance, fueled by strong demand for its electrophysiology devices, signal a strategic shift. The company is navigating tariff pressures while expanding margins, with major acquisitions poised to reshape its long-term profile.
Boston Scientific (BSX) is attracting bullish analyst attention after its strategic acquisition of Penumbra, with Truist Securities reiterating a Buy rating and a $120 price target, citing enhanced business durability and growth prospects.
Thermo Fisher Scientific reported a strong finish to 2025, with Q4 results exceeding expectations. While navigating currency volatility and tariffs, the life sciences giant highlighted growth in core biopharma sectors, strategic acquisitions like Clario, and a solid 2026 outlook.
Wall Street firms Keefe Bruyette and BTIG have raised price targets on Core Scientific, citing the company's strategic shift from Bitcoin mining to high-performance computing infrastructure for AI as a key driver for future growth.
A federal appeals court has dismissed a Justice Department misconduct complaint against U.S. District Judge James Boasberg, ruling the government failed to substantiate its allegations regarding the judge's public comments.
Seventeen-year-old Hailey Buzbee vanished after leaving her Vermillion home in early January. Authorities now believe she is deceased and have arrested a man she met through online gaming, though murder charges have not yet been filed.
The search for Isabella Comas, last seen in Avondale on January 11, continues after her abandoned car was discovered with blood stains. Her boyfriend, Thomas Rodriguez, a convicted felon, is in custody on unrelated charges as authorities plead for public assistance.
With its patented, FDA-recognized compound Niagen®, Niagen Bioscience (NAGE) has carved out a unique and defensible position at the intersection of nutraceuticals and pharmaceuticals. As the cellular health market expands, the company's dual-channel strategy and deep scientific validation present a compelling growth narrative for investors.
Authorities in Mobile County are urgently searching for a missing mother, her teenage daughter, and toddler son after discovering evidence of a disturbance at their residence, indicating they may have been taken against their will.
While AI's role in headline-grabbing discoveries like AlphaFold is celebrated, Anthropic is forging a new path. Through partnerships with the Allen Institute and HHMI, the company is embedding Claude AI into the unglamorous, time-consuming groundwork of research—betting that efficiency gains in data analysis and coordination will compress decades of scientific progress.
Senator James Lankford's annual oversight report details what he calls wasteful federal spending, including controversial NIH-funded projects on transgender-related animal testing and aborted fetal tissue research, reigniting debates on scientific priorities and fiscal responsibility.
Newly released video evidence shows Islamic State fighters moving unchallenged among aircraft at Niamey's Diori Hamani International Airport, igniting regional tensions and raising urgent questions about security in the Sahel.
A federal appeals court has dismissed a Justice Department misconduct complaint against U.S. District Judge James Boasberg, citing insufficient evidence. The complaint stemmed from the judge's rulings against the Trump administration's use of the Alien Enemies Act to deport Venezuelan migrants.
A senior Justice Department official has indicated that the recent massive release of Jeffrey Epstein-related documents is unlikely to lead to new federal prosecutions, stating that the trove of 'horrible photographs' and emails does not itself constitute prosecutable evidence, even as the revelations trigger political fallout abroad.
A federal appeals court has thrown out a Justice Department misconduct complaint against a judge who blocked deportations to El Salvador's notorious prisons, citing a lack of evidence. The ruling highlights ongoing tensions between the judiciary and executive branch over immigration enforcement.
In a striking departure from diplomatic norms, Prime Minister Keir Starmer has publicly called on the disgraced Duke of York to provide evidence to the U.S. Congressional investigation into Jeffrey Epstein. The intervention signals a collapse of the traditional political shield around the monarchy and intensifies legal and reputational pressures on Andrew.
A firefighter has been convicted and sentenced to life in prison for the 2020 murder of Melissa Lamesch, who was days from giving birth to his son, and for setting her home ablaze in an attempt to destroy evidence.
After the COVID-19 windfall subsided, Pfizer CEO Albert Bourla is steering the pharmaceutical giant into a high-stakes, $23 billion pivot to cancer research. Facing a looming patent cliff and plummeting vaccine revenue, Bourla is betting on scientific innovation to secure the company's future—and redefine cancer treatment.
